Drugs / IONIS-PKKRx
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT03108469 Comparator | Aug 2017 → Apr 2019 | migraine disorder | Smith, Timothy R., M.D. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IONIS-PKKRx | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03108469 ↗ |
| Known as | ISIS 546254 | “IONIS-PKKRx (ISIS 546254)” NCT03108469 ↗ |
| Route | Subcutaneous | “repeated subcutaneous administration of IONIS-PKKRx (ISIS 546254)” NCT03108469 ↗ |